MESSAGE FROM EXECUTIVE.html
Message from the Executive
In late March 2012, all the elected members
of the Board of the Southern African HIV Clinicians Society met for the
first time under my leadership to discuss the way forward. We decided
that our objectives would now include partnering with governments to
implement optimal HIV programmes and policies. For South Africa, this
means doing all we can to assist the government to achieve the goals of
National Strategic Plan 2012 - 2016.
In line with this objective, we faced the following challenge
in the ensuing weeks: We received reports from a number of sites that
there were some medication stock-outs, including Tenofovir. Concerned
healthcare workers wanted to know how they could provide for their
patients. Knowing that treatment interruptions have long-term
consequences in terms of resistance as well as other complications,
many healthcarers were not sure how to handle drug shortages. Some
patients can have treatment substitutions, so we convened a virtual ad
hoc committee of the brains trust of the Society. Within a matter of
days, we drafted a consensus statement that was sent to the
Director-General of Health (and is included in this issue). As we went
through this process, I was struck by the depth of experience we have
in the Society. Our brains trust must be unequalled anywhere in the
world.
To now assist the Department of Health, we are implementing an SMS
stock-out line for healthcare workers to report drug shortages. All
reports will be submitted to the Department of Health every second week
of each month. We will monitor shortage trends and the progress towards
resolution. Enclosed is a stock-out report form that includes details
of applicable drugs and information on how to report shortages.
Another area we have agreed to focus on is the improvement of
TB diagnosis, care and prevention within the context of the HIV
epidemic. We have made many remarkable achievements in the diagnosis,
care and treatment of HIV infection, and we need to repeat this for TB.
The overlap between the two epidemics is very substantial. For the
first time in my career, there have been some new and exciting
developments. The GeneXpert technology has been adopted in a bold move
for the diagnosis of TB. The Department of Health has announced that
ART should be provided for all HIV-infected individuals who get TB,
irrespective of their CD4.
It seems to me that we are now at a stage in the TB epidemic
where we were about 10 years ago in the HIV epidemic. We are on the
brink of new interventions and there is renewed drive within the
Department to tackle the problems. But the task ahead is huge. About 1%
of South Africans contract TB every year. Will we achieve the NSP goal
of a reduction of this incidence rate by half within 5 years? To my
mind, we can only do so if we apply the same determination that we did
in the HIV arena. TB is our next battle, and looming behind that is the
ever-increasing burden of drug-resistant TB.
Finally, please don’t forget that we have a conference
coming up at the end of the year in Cape Town from 25 - 28 November.
Entitled ‘Striving for Clinical Excellence’, this is a
conference that I think all southern African HIV clinicians should
attend. There is no better way to spend the last week in November than
in the Mother City – rubbing shoulders with the best extant HIV
healthcare workers.
Francesca Conradie
President
Southern African HIV Clinicians Society
Johannesburg
MESSAGE